Gut bacteria and estrogen regulate each other through an enzyme called beta-glucuronidase, and real shifts happen through perimenopause: less Lactobacillus and Bifidobacterium, more of several less favorable strains. What hasn’t been established is a target microbiome to aim for, or that a stool test can currently tell you what to do about any of this.
Nineteen years in a lab that lived and died by bacterial counts, and I still catch myself skeptical every time “gut bacteria” gets offered up as the tidy explanation for something. Not because the underlying biology isn’t real. Because it usually gets presented as far simpler and more actionable than it currently is.
So let’s do this properly, the way I’d want it explained to me. There is a real, named mechanism connecting your gut bacteria to your estrogen levels. There is real data on how your microbiome shifts through the menopause transition. And there is a real, current gap between what’s been measured and what any of it actually tells you to do about it, and I’d rather show you exactly where that gap sits than pretend it’s already closed.
The estrobolome, actually explained
Your liver processes used estrogen by attaching a molecule to it that makes it water-soluble, so it can be excreted through bile into your intestines and out. That’s the exit ramp. But certain gut bacteria produce an enzyme called beta-glucuronidase, which can cut that molecule back off, reactivating the estrogen so it gets reabsorbed into your bloodstream instead of leaving your body.
That collection of bacterial genes capable of doing this is what researchers actually call the estrobolome. It’s not a separate organ or a single distinct group of species. It’s a function, distributed across whichever bacteria in your particular gut happen to carry the right genes, and it directly affects how much of your own estrogen gets recirculated back into you versus cleared out for good.
The relationship runs both directions. Estrogen levels shape which bacteria thrive in your gut, and those bacteria in turn influence how much estrogen gets reabsorbed. When estrogen production changes through perimenopause, the microbiome shifts in response, and that shift changes the estrobolome’s activity, which feeds back into your circulating estrogen. It’s a loop, not a one-way street.
What actually changes in your gut bacteria
This part has real measurement behind it, not just theory. Through the menopause transition, several patterns show up consistently across studies: Lactobacillus and Bifidobacterium, generally considered favorable genera, tend to decrease, while Enterobacter, generally less favorable, tends to increase. Firmicutes and a genus called Roseburia are frequently depleted, while Bacteroidetes and a species called Tolumonas become more prominent.
The overall direction by the time a woman is fully postmenopausal is toward lower microbial diversity, lower resilience, reduced estrobolome capacity, and a shift toward a more pro-inflammatory bacterial profile. None of that is exotic or disputed. It’s a fairly consistent finding across the research, and it lines up with the same broader pattern of hormonal volatility driving change through this transition, not just in your gut’s bacterial population but in how the gut muscle itself behaves.
Lower diversity specifically is worth understanding, because it gets used loosely in marketing. It means fewer distinct species and a less even distribution among them, which in general population research correlates with lower resilience to disruption, not a specific symptom or a specific number you’re failing to hit. A diversity score on a consumer report isn’t a grade. It’s a description of one snapshot of a moving system.
That last framing matters more than the impressive sample size does. Thirty-two predictive species, found through machine learning across seventy thousand women, is genuine, current evidence that the connection is real. It is not the same thing as knowing what any one woman’s own 32 species mean for her, or what to do about it. The researchers who ran the study said so themselves.
Why a stool test won’t hand you an answer yet
Here’s the part the supplement and testing industry tends to skip. No study has established what a correct, target microbiome looks like for a woman in perimenopause. There’s no validated reference range that a commercial stool test can compare your results against and generate a specific, individual action from. The 2025 study found bacteria that correlate with symptoms across a large population. It did not produce a “your Lachnospiraceae is low, take this” recommendation, because that’s not what population-level correlation gives you.
I spent nineteen years reading papers the way quality control taught me to: sample size, funding source, and whether the conclusion actually follows from the data. A test that hands you a report with red and green markers, priced like it’s precision medicine, is currently ahead of what the underlying science can support for an individual result.
| What’s established | What isn’t | |
|---|---|---|
| The mechanism | Beta-glucuronidase reactivates estrogen for reabsorption | None |
| The shift | Diversity and specific genera change through the transition | Exactly why, for each woman, or how fast |
| The 2025 study | 32 species predict symptom severity across 70,399 women | What any individual’s own species profile means |
| Commercial testing | Can sequence what’s present in your sample | Cannot yet map that to a validated, individual action |
What this looks like in practice
Not a protocol, since the honest version of this mechanism doesn’t currently produce one.
Population data isn’t personal data. A finding that holds across seventy thousand women tells you the mechanism is real. It doesn’t tell you what your own gut is doing, or what to change based on a single stool sample.
Be skeptical of any product that names your bacteria and prescribes a fix in the same paragraph. The gap between “this species correlates with symptoms” and “take this supplement to fix it” is exactly the gap the current research hasn’t closed. The same caution applies to probiotic marketing generally, where dose and strain claims routinely outrun what’s actually been tested.
The mechanism connecting hormones and bacteria is real even without a personalized fix. Understanding that your estrogen and your gut bacteria are genuinely in conversation with each other is useful on its own, alongside the other hormone mechanisms already covered, even before the field produces something actionable from it.
Bacteria aren’t the only thing estrogen is negotiating with in your gut. A separate mechanism involving histamine and an enzyme called DAO explains why specific foods, not just overall digestion, can start acting up around the same time.
If you’re on hormone therapy, you’ve changed the input this system acts on. The estrobolome works on whatever estrogen reaches it, prescribed or your own, and what the research actually shows about hormone therapy and bloating is a separate question with its own mixed literature. Not a reason to start or stop anything. Just what has been measured.
Common questions
Is the estrobolome a real, scientifically accepted concept, or marketing language?
Yes. Gut bacteria producing beta-glucuronidase, and thereby influencing estrogen reabsorption, is established, published mechanism, not a wellness-industry invention. What’s overstated is how precisely it’s currently understood at the individual level.
Can I test my estrobolome specifically?
Commercial stool tests can sequence which bacteria are present and estimate some enzyme activity, but there’s no validated reference range tying a specific result to a specific recommendation for perimenopausal women.
Does this mean probiotics can rebalance my hormones?
Not currently, in any way of study that supports a specific product claim. The mechanism connecting bacteria and estrogen is real; a validated intervention that reliably shifts it in a beneficial direction, for a known symptom benefit, hasn’t been established.
What did the 2025 study with 70,000 women actually find?
That a machine-learning model, using gut microbiome data, could predict how severe a woman’s menopause symptoms were likely to be, and identified 32 bacterial species associated with that prediction. It did not produce individualized treatment recommendations.
Why does my gut bacteria composition matter if there’s no fix yet?
Because understanding a real mechanism changes what claims deserve your money and attention right now, even before an actionable fix exists. It also means future research in this area is genuinely worth paying attention to, rather than dismissing the whole topic as unfounded because today’s tests overpromise.
The bacteria-hormone connection is real, and currently short on individual answers. What actually helps, graded by how much evidence backs it, is a different and more useful question.
Fortylight is written by Nina Halvorsen, a food scientist, not a physician, dietitian, or licensed health professional. Nothing here is medical advice. Digestive symptoms can signal serious conditions. If you have blood in your stool, unexplained weight loss, persistent vomiting, difficulty swallowing, bleeding after menopause, or symptoms that began after age 50, see a doctor before trying anything on this site.